ciprofloxacin has been researched along with sulfamethoxazole in 137 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (16.79) | 18.7374 |
| 1990's | 5 (3.65) | 18.2507 |
| 2000's | 20 (14.60) | 29.6817 |
| 2010's | 57 (41.61) | 24.3611 |
| 2020's | 32 (23.36) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YT; Lauderdale, TL; Liao, TL; Shiau, YR; Shu, HY; Su, IJ; Tsai, SF; Wu, KM; Yan, JJ | 1 |
| Liu, Y; Shi, W; Wang, M; Wu, S; Xu, X; Ye, X; Zhang, Y | 1 |
| Campbell, BJ; Edwards, SW; Hart, CA; Martin, HM; Rhodes, JM; Roberts, CL; Subramanian, S | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Chen, H; Chen, M; Wang, H; Yang, H; Yang, Q | 1 |
| Chen, Z; Deng, Y; Huang, L; Liu, J; Lü, D; Ma, J; Wang, M; Wang, X; Xu, X; Zeng, Z; Zhang, Y | 1 |
| Guo, Q; Hooper, DC; Wang, M; Wang, X; Wu, S; Xu, X; Ye, X | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Damle, AJ; Palekar, VS; Shukla, SR | 1 |
| Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH | 1 |
| Fuller, CA; McGannon, CM; Weiss, AA | 1 |
| Chan, JL; Cheung, GY; Joo, HS; Otto, M | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Agarwal, DD; Gupta, SK; Lal, J; Thavaselvam, D | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Kazancioglu, MZ; Sacher, JR; Saha, J; Skoda, EM; Wipf, P | 1 |
| Almayah, AA; Bolandnazar, Z; Ebrahimi, A; Ebrahimi, HP; Hadi, JS; Swadi, AG | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Guo, H | 1 |
| Ferro, S; Low, DE; Simor, AE | 1 |
| Dent, J; McNulty, CA; Wise, R | 1 |
| Boerema, JB | 1 |
| Ariza, J; Bosch, J; Cisnal, MC; Liñares, J; López de Goicoechea, MJ; Martin, R | 1 |
| Nevárez, M; Ramírez-Ronda, CH; Saavedra, S | 1 |
| Birnbaum, D; Krause, B; Lenk, V; Trautmann, M; Wagner, J | 1 |
| Kapell, KS; Kessler, HA; Segreti, J; Trenholme, GM | 1 |
| Smith, JM; Steele, LC; Sumter, G; Wallace, RJ | 1 |
| Dekker, A; Rozenberg-Arska, M; Verhoef, J | 1 |
| Hohl, P; Kafader, FM; Salfinger, M | 1 |
| de Micco, P; Gevaudan, MJ; Gulian, C; Lagier, P; Mallet, MN; Terriou, P | 1 |
| Cullmann, W; Dechène, M; Stieglitz, M | 1 |
| Allais, JM; Bittner, MJ; Cuevas, TA; Mellencamp, MA; Preheim, LC; Roccaforte, JS | 1 |
| Chan, V; Noble, MA | 1 |
| Bourgeois, AL; Hyams, KC; Lissner, CR; Mikhail, IA; Podgore, JK; Walz, S | 1 |
| Dekker, AW; Rozenberg-Arska, M | 1 |
| Grubbs, NC; Henry, NK; Ilstrup, DM; Muller, SM; Schultz, HJ; Wilson, WR | 1 |
| Grüneberg, RN; Williams, AH | 1 |
| Bitsura, JA; de la Cabada, FJ; Dupont, HL; Ericsson, CD; Johnson, PC; Morgan, DR | 1 |
| Andriole, VT; Berenson, CS; Greco, TP; Mangi, RJ; Ryan, JL; Sims, M; Thornton, GF | 1 |
| D'Costa, LJ; Greenblatt, RM; Naamara, W; Ndinya-Achola, JO; Plummer, FA; Ronald, AR | 1 |
| DuPont, HL; Ericsson, CD; Johnson, PC; Robinson, A | 1 |
| Koornhof, HJ; Saunders, J; Shrire, L; Traynor, R | 1 |
| Behets, FM; Cohen, MS; Dallabetta, G; Hamilton, HA; Hoffman, IF; Liomba, G; Lule, G; Moeng, S | 1 |
| Florio, A; Locatelli, A; Rambaldi, A; Rosario, P; Ruggiero, G; Tripodi, MF; Utili, R | 1 |
| Bergmann, JS; Boulet, B; Brown, BA; Fahle, GA; Plaunt, M; Wallace, RJ; Wanger, A; Witebsky, FG; Woods, GL | 1 |
| Hartzema, AG; Huang, X; Kauf, TL; Norwood, GJ; Raasch, RH | 1 |
| Dalsgaard, A; Guardabassi, L; Olsen, JE | 1 |
| Shaikh, N; Tarr, PI | 1 |
| Harigae, H; Ishikawa, S; Kaku, M; Kanemitsu, K; Kunishima, H; Saga, T; Takemura, H | 1 |
| Amábile-Cuevas, CF; Arredondo-García, JL; Cardeñosa-Guerra, O; Corral, M; Costa, A; Figueroa-Damián, R; Hernández-Oliva, GM; Jáuregui, A; Merlos, RM; Olguín, J; Ríos-Fabra, A; Rosas, A | 1 |
| Aga, DS; Batt, AL; Bruce, IB | 1 |
| Depta, JP; Lüthi, M; Pichler, WJ; Schmid, DA | 1 |
| Berger, B; Chan, CK; Joondeph, BC | 1 |
| Gagnon, C; García-Ac, A; Ghosh, D; Lajeunesse, A; Sauvé, S; Segura, PA | 1 |
| Becket, E; Bui, A; Hong, J; Kim, K; Liu, A; Miller, JH; Sitz, D; Solaimani, P; Tamae, C; Tran, KP; Yang, H | 1 |
| Lajiness, MJ | 1 |
| Avisar, D; Lester, Y; Mamane, H | 1 |
| Biedenbach, DJ; Castanheira, M; Jones, RN | 1 |
| Accinelli, C; Batisson, I; Fick, J; Grabic, R; Mencarelli, M; Saccà, ML | 1 |
| Chakraborty, A; Gloriani, NG; Miyahara, S; Villanueva, SY; Yoshida, S | 1 |
| Jayaraman, P; Lim, CS; Sakharkar, KR; Sakharkar, MK; Tang, TH | 1 |
| Bosscher, VA; Cok, RC; Hozalski, RM; Wunder, DB | 1 |
| Guan, C; Liu, BY; Liu, WQ; Nie, XP; Snoeijs, P; Tsui, MT | 1 |
| Chen, H; Gao, B; Li, H; Ma, LQ | 1 |
| Alliot, F; Chevreuil, M; Dinh, QT; Eurin, J; Labadie, P; Moreau-Guigon, E | 1 |
| Herodes, K; Kipper, K; Leito, I; Nei, L | 1 |
| Anselmo, A; Fiorentino, A; Rizzo, L | 2 |
| Conkle, JL; White, JR | 1 |
| Alam, M; Colwell, RR; Cravioto, A; Huq, A; Islam, MT; Johura, FT; Mannan, SB; Rashed, SM; Sack, RB; Sadique, A; Watanabe, H | 1 |
| Liu, BY; Liu, WQ; Nie, XP; Yang, YF; Yu, HJ | 1 |
| Gruszczyńska, B; Kaznowski, A; Mokracka, J | 1 |
| Ekin, IH; Ilhan, Z; Solmaz, H | 1 |
| Chen, F; Chen, H; Fu, W; Luo, W; Meng, F; Xie, Y; Yang, X; Ye, T; Young, K | 1 |
| Chovelon, JM; Ferronato, C; Ji, Y; Salvador, A; Yang, X | 1 |
| Chen, H; Gao, B; Li, H | 1 |
| Barrett, K; Corcoran, M; Inglis, S; Martin, P; Pierce, D; Preston, P; Thompson, TN; Willsie, SK | 1 |
| Backhaus, T; Janmar, L; Johansson, CH | 1 |
| Dumont, E; Johnson, AC; Keller, V; Sumpter, JP | 1 |
| Bouyarmane, H; Coradin, T; El Hanbali, I; El Karbane, M; Laghzizil, A; Masse, S; Rami, A; Saoiabi, A; Saoiabi, S | 1 |
| Gao, P; Li, KZ; Liu, ZH; Wang, K; Xue, G; Zhou, YY | 1 |
| Chiemchaisri, C; Chiemchaisri, W; Hamjinda, NS; Honda, R; Watanabe, T | 1 |
| Amparo, MR; Carvalho, LS; Chatila, S; Lima Gomes, PC; Penteado, ED; Santos-Neto, ÁJ; Tomita, IN; Zaiat, M | 1 |
| Antonello, VS; Dallé, J; Jimenez, MF; Kronbauer, K; Riche, CW; Rocha-Castro, J; Santiago, JA | 1 |
| Gallert, C; Heß, S | 1 |
| Christofilopoulos, S; Kalogerakis, N; Politi, M; Syranidou, E; Vangronsveld, J; Venieri, D; Weyens, N | 1 |
| Chen, S; Gao, B; Li, X; Liu, Y; Zhang, J | 1 |
| Cason, L; Chalasani, P; Dahya, V; Kuretski, J; Ramgopal, M | 1 |
| Acharya, K; Bai, X | 1 |
| Campo, RD; Carrola, J; Carvalho, I; Carvalho, S; Cobo, M; Igrejas, G; Marinho, C; Nóvoa, M; Pereira, JE; Poeta, P; Quaresma, M; Santos, T; Silva, N; Sousa, M | 1 |
| Abbas, A; Ahmed, Z; Zahoor, M | 1 |
| Andriamalala, A; Cambier, P; Dumeny, V; Vieublé-Gonod, L | 1 |
| Cheng, JS; Gao, N; Liu, CX; Xu, QM; Yuan, YJ | 1 |
| Acuña, V; Balcázar, JL; Borrego, CM; Sabater, S; Sànchez-Melsió, A; Subirats, J; Timoner, X | 1 |
| Martins, M; Pereira, IAC; Sanches, S | 1 |
| Ademollo, N; Caracciolo, AB; Cardoni, M; Grenni, P; Levantesi, C; Luprano, ML; Patrolecco, L; Rauseo, J | 1 |
| Aderemi, AO; Alves, LM; Hunter, C; Lemos, MFL; Novais, SC; Pahl, O | 1 |
| Lin, AY; Lin, YC; Liu, LC; Panchangam, SC | 1 |
| Carneiro, RB; Sabatini, CA; Santos-Neto, ÁJ; Zaiat, M | 1 |
| Harrison, KR; Kappell, AD; McNamara, PJ | 1 |
| Giebułtowicz, J; Harnisz, M; Korzeniewska, E; Kucharski, D; Nałęcz-Jawecki, G; Płaza, G | 1 |
| Cizmas, L; Feng, M; Kovalakova, P; Marsalek, B; McDonald, TJ; Sharma, VK | 1 |
| Li, H; Ryser, ET; Shen, Y; Zhang, W | 1 |
| Carneiro, RB; Mukaeda, CM; Sabatini, CA; Santos-Neto, ÁJ; Zaiat, M | 1 |
| Bottega, A; Coelho, SS; Foletto, VS; Hörner, R; Lorenzoni, VV; Machado, CS; Mainardi, A; Rampelotto, RF; Rosa, TFD; Serafin, MB | 1 |
| Niemissalo, SM; Pihlaja, TLM; Sikanen, TM | 1 |
| Bizi, M; El Bachra, FE | 1 |
| Fatehi, P; Feizi, ZH | 1 |
| Barak Levitt, J; Barmatz, S; Dalal, A; Fisch-Gilad, S; Hackett, A; Hodak, E; Kremer, N; Levi, A; Pavlovsky, L; Sherman, S; Taieb, Y; Yahav, D | 1 |
| Green, MD; Khanthavong, M; Mayxay, M; Newton, PN; Phonlavong, C; Sengaloundeth, S; Sichanh, C; Swamidoss, I; Tabernero, P; Vilayhong, C | 1 |
| Mabiki, F; Malebo, HM; Mariki, EE; Mdegela, R; Mwankuna, CJ; Styrishave, B; Uwamaliya, GA | 1 |
| Arsand, JB; Jank, L; Pizzolato, TM; Schwalm, CS; Segalin, J; Streit, L | 1 |
| Boncz, MÁ; López-Serna, R; Muñoz, R; Ruas, G; Scarcelli, PG; Serejo, ML | 1 |
| Catalá-Gregori, P; Cortés, V; García, C; Marín, C; Sevilla-Navarro, S | 1 |
| Becerra-Aparicio, F; Fuchs, F; Higgins, PG; Seifert, H; Xanthopoulou, K | 1 |
| Borges-Mateus, LM; Carmona-Cartaya, Y; González-Molina, MK; Hidalgo-Benito, M; Pereda-Novales, N; Quiñones-Pérez, D | 1 |
| Ali, MM; Ijaz, M; Muzammil, I; Saleem, MH | 1 |
| Fan, X; Kang, X; Luo, S; Luo, X; Wang, G; Wei, Y; Zhao, S | 1 |
| Aerts, M; Alvarez, J; Collado, S; de Frutos, C; Dominguez, L; Jaspers, S; Moreno, MA; Saez, JL; Teng, KT; Ugarte-Ruiz, M | 1 |
| Chen, H; Di, X; Ding, J; Lin, J; Sun, W; Zhang, H | 1 |
| Barbosa, SC; Chaves, MJS; Kulzer, J; Primel, EG; Pujol de Lima, PDR | 1 |
| Kassie, GM; Kerr, M; Moffat, A; Pratt, N; Roughead, EE | 1 |
| Chang, SC; Hidrosollo, JH; Kao, CY; Lin, LC; Lu, JJ; Ou, YH | 1 |
| Barra Caracciolo, A; Garbini, GL; Grenni, P; Mariani, L; Massini, G; Mazzurco Miritana, V; Patrolecco, L; Rauseo, J; Spataro, F; Visca, A | 1 |
| Cao, W; Hao, Q; Li, Q; Li, Y; Liu, C; Liu, Y; Shi, G; Wu, L | 1 |
| Chen, B; Lu, L; Pan, L; Wang, R; Wu, J; Zhu, X | 1 |
| Alonso, E; Aparicio, I; Gómez-Regalado, MDC; Hidalgo, F; Martín, J; Santos, JL; Zafra-Gómez, A | 1 |
| Kannabiran, K; Mukherjee, A; Roy, N | 1 |
| Akinsete, SJ; Egbeyemi, MM; Ewemoje, TA; Lateef, SA; Omobowale, MO | 1 |
| Dueñas-Moreno, J; Giri, BS; Kumar, M; Mahlknecht, J; Mora, A; Raval, NP; Silori, R; Tauseef, SM; Zang, J | 1 |
| Choi, HJ; Choi, JY; Choi, YH; Kim, C; Park, RW; Rhie, SJ | 1 |
4 review(s) available for ciprofloxacin and sulfamethoxazole
| Article | Year |
|---|---|
Isatin derivatives and their anti-bacterial activities.
Topics: Anti-Bacterial Agents; Bacteria; Humans; Isatin; Structure-Activity Relationship | 2019 |
Current problems in antimicrobial therapy for bacterial enteric infection.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clinical Trials as Topic; Diarrhea; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Occurrence and toxicity of antibiotics in the aquatic environment: A review.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Aquatic Organisms; Ciprofloxacin; Ecotoxicology; Environmental Monitoring; Erythromycin; Groundwater; Risk Assessment; Sulfamethoxazole; Tetracycline; Trimethoprim; Water Pollutants, Chemical | 2020 |
Updated knowledge, partitioning and ecological risk of pharmaceuticals and personal care products in global aquatic environments.
Topics: Aquatic Organisms; Ciprofloxacin; Cosmetics; COVID-19; Environmental Monitoring; Humans; Pharmaceutical Preparations; Sulfamethoxazole; Water Pollutants, Chemical | 2022 |
12 trial(s) available for ciprofloxacin and sulfamethoxazole
| Article | Year |
|---|---|
Ciprofloxacin in the treatment of urinary tract infections caused by Pseudomonas aeruginosa and multiresistant bacteria.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1986 |
Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug Combinations; Drug Therapy, Combination; Humans; Infection Control; Leukemia; Neomycin; Neutropenia; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Randomized, double-blind comparison of ciprofloxacin and trimethoprim-sulfamethoxazole for complicated urinary tract infections.
Topics: Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Random Allocation; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 1988 |
Ciprofloxacin for infection prevention in patients with acute leukemia.
Topics: Adult; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug Combinations; Drug Therapy, Combination; Humans; Leukemia; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women.
Topics: Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Double-Blind Method; Drug Combinations; Female; Humans; Prospective Studies; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1986 |
Ciprofloxacin and co-trimoxazole in urinary tract infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Combinations; Female; Humans; Male; Middle Aged; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1986 |
Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial.
Topics: Adult; Ciprofloxacin; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Drug Combinations; Humans; Placebos; Prospective Studies; Random Allocation; Sulfamethoxazole; Time Factors; Travel; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Oral ciprofloxacin in resistant urinary tract infections.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Pseudomonas Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial.
Topics: Adolescent; Adult; Chancroid; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Current problems in antimicrobial therapy for bacterial enteric infection.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clinical Trials as Topic; Diarrhea; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Administration Schedule; Female; Humans; Latin America; Norfloxacin; Premenopause; Prospective Studies; Sulfamethoxazole; Time Factors; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2004 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Female; Humans; Male; Mesalamine; Metronidazole; Middle Aged; Sulfamethoxazole | 2014 |
122 other study(ies) available for ciprofloxacin and sulfamethoxazole
| Article | Year |
|---|---|
Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Genomics; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2007 |
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cells, Cultured; Colon; Crohn Disease; Culture Media; Escherichia coli; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Monocytes; Mucous Membrane | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Prevalence; Quinolones | 2008 |
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
Topics: Acetyltransferases; Adolescent; Adult; Aged; Animals; Animals, Domestic; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cambodia; Cephalosporins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Female; Humans; Male; Mali; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Plasmids; Quinolones; Young Adult | 2009 |
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Synthesis and antibacterial activity of some novel bis-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and bis-4-thiazolidinone derivatives from terephthalic dihydrazide.
Topics: Anti-Bacterial Agents; Hydrazines; Microbial Sensitivity Tests; Molecular Structure; Oxadiazoles; Phthalic Acids; Thiadiazoles | 2009 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea | 2010 |
Different classes of antibiotics differentially influence shiga toxin production.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteriophages; Ciprofloxacin; Escherichia coli; Escherichia coli O157; Shiga Toxin; Sulfamethoxazole; Trimethoprim | 2010 |
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cytotoxins; Methicillin-Resistant Staphylococcus aureus; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators; Virulence | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Biological activity, design, synthesis and structure activity relationship of some novel derivatives of curcumin containing sulfonamides.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antineoplastic Agents; Bacteria; Cell Proliferation; Curcumin; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Fungi; HCT116 Cells; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
An uncharged oxetanyl sulfoxide as a covalent modifier for improving aqueous solubility.
Topics: | 2014 |
Metal-based biologically active azoles and β-lactams derived from sulfa drugs.
Topics: Anti-Bacterial Agents; Azoles; Bacteria; Bacterial Infections; beta-Lactams; Coordination Complexes; Humans; Ligands; Microbial Sensitivity Tests; Models, Molecular; Schiff Bases; Sulfamethoxazole; Sulfathiazole; Sulfathiazoles | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.
Topics: Ampicillin; Anti-Infective Agents; Campylobacter; Ciprofloxacin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Nitrofurantoin; Sulfamethoxazole; Tetracycline; Trimethoprim | 1989 |
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
Topics: Anti-Bacterial Agents; Bismuth; Campylobacter; Cefoxitin; Ciprofloxacin; Erythromycin; Gastritis; Gentamicins; Humans; Metronidazole; Nalidixic Acid; Organometallic Compounds; Penicillin Resistance; Penicillins; Quinolines; Sulfamethoxazole; Tartrates; Trimethoprim | 1985 |
New 4-quinolones in the treatment of urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Combinations; Humans; Male; Norfloxacin; Pefloxacin; Prostatitis; Pseudomonas Infections; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Bladder, Neurogenic; Urinary Tract Infections | 1986 |
In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis.
Topics: Anti-Bacterial Agents; Brucella; Brucellosis; Ceftriaxone; Ciprofloxacin; Drug Combinations; Humans; Microbial Sensitivity Tests; Quinolines; Sulfamethoxazole; Tetracyclines; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Serum bactericidal activity of two newer quinolones against Salmonella typhi compared with standard therapeutic regimens.
Topics: Adult; Amoxicillin; Chloramphenicol; Ciprofloxacin; Drug Combinations; Female; Humans; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxazines; Quinolines; Salmonella typhi; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Combinations; Erythromycin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Antimicrobial susceptibility patterns of Nocardia asteroides.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Nocardia asteroides; Nocardia Infections; Sulfamethoxazole | 1988 |
In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
Topics: Amikacin; Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Combinations; Fleroxacin; Mycobacterium; Nontuberculous Mycobacteria; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
[Sensitivity of 7 mycobacterial species to new quinolones].
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sulfamethoxazole; Thienamycins; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[Comparative antibacterial activity of fleroxacin: selection frequencies and outer membrane proteins of resistant mutants].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Outer Membrane Proteins; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Humans; Mutation; Ofloxacin; Serratia marcescens; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Ciprofloxacin treatment of Salmonella hadar epididymo-orchitis.
Topics: Adult; Ciprofloxacin; Drug Combinations; Epididymitis; Humans; Male; Orchitis; Salmonella Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
In vitro activity of ciprofloxacin compared to trimethoprim-sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli causing travellers' diarrhea in Egypt.
Topics: Anti-Bacterial Agents; Campylobacter; Ciprofloxacin; Diarrhea; Drug Combinations; Drug Resistance, Microbial; Egypt; Escherichia coli; Humans; Shigella; Sulfamethoxazole; Travel; Trimethoprim; Trimethoprim Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Microbial; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Sexually transmitted diseases and human immunodeficiency virus control in Malawi: a field study of genital ulcer disease.
Topics: Chancroid; Ciprofloxacin; Erythromycin; Genital Diseases, Male; HIV Infections; Humans; Malawi; Male; Penicillin G Benzathine; Skin Ulcer; Sulfamethoxazole; Syphilis; Trimethoprim | 1995 |
Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillins; Sulfamethoxazole; Trimethoprim | 1996 |
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Culture Media; Doxycycline; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sulfamethoxazole; Tobramycin | 1999 |
Economic assessment of three antimicrobial therapies for uncomplicated urinary tract infection in women.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Insurance, Health, Reimbursement; Medicaid; Middle Aged; Nitrofurantoin; North Carolina; Polypharmacy; Sulfamethoxazole; Time Factors; Treatment Outcome; Trimethoprim; United States; Urinary Tract Infections | 1999 |
Phenotypic characterization and antibiotic resistance of Acinetobacter spp. isolated from aquatic sources.
Topics: Acinetobacter; Amoxicillin; Bacterial Typing Techniques; Chloramphenicol; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Microbial; Fresh Water; Gentamicins; Microbial Sensitivity Tests; Oxytetracycline; Phenotype; Sewage; Sulfamethoxazole; Water Microbiology | 1999 |
Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteriophages; Bile Acids and Salts; Chromosome Mapping; Ciprofloxacin; Escherichia coli O157; Fosfomycin; Genome, Bacterial; Molecular Sequence Data; Recombination, Genetic; Shiga Toxin; Shiga Toxin 1; Shiga Toxin 2; Sulfamethoxazole; Trimethoprim; Virulence; Virus Integration | 2003 |
Efficacy of amikacin combinations for nocardiosis.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Ciprofloxacin; DNA, Ribosomal; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Male; Middle Aged; Minocycline; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Streptomyces; Sulfamethoxazole; Trimethoprim | 2003 |
Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges.
Topics: Anti-Bacterial Agents; Caffeine; Chromatography, Liquid; Ciprofloxacin; Clindamycin; Environmental Monitoring; Spectrum Analysis; Sulfamethoxazole; Tetracycline; Trimethoprim; Waste Disposal, Fluid; Water Movements; Water Pollutants, Chemical; Water Pollution; Water Purification | 2006 |
Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds.
Topics: Animals; B-Lymphocytes; CD3 Complex; CD4 Antigens; Cell Line, Transformed; Cells, Cultured; Ciprofloxacin; Cross Reactions; Drug Interactions; Flow Cytometry; Humans; Hybridomas; Interleukin-2; Mice; Norfloxacin; Quinolones; Receptors, Antigen, T-Cell; Sulfamethizole; Sulfamethoxazole; Sulfanilamides; T-Lymphocytes; Time Factors; Transfection | 2006 |
Diagnostic and therapeutic challenges.
Topics: Anti-Infective Agents; Blindness; Ciprofloxacin; Drug Therapy, Combination; Eye Infections, Parasitic; Female; Fluorescein Angiography; Granuloma; Humans; Middle Aged; Retinal Diseases; Retinal Hemorrhage; Sulfamethoxazole; Tomography, Optical Coherence | 2007 |
Determination of six anti-infectives in wastewater using tandem solid-phase extraction and liquid chromatography-tandem mass spectrometry.
Topics: Anti-Infective Agents; Azithromycin; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Ofloxacin; Sewage; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Trimethoprim; Water Pollutants, Chemical | 2007 |
Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Genes, Bacterial; Gentamicins; Metronidazole; Microbial Sensitivity Tests; Mutation; Rifampin; Sulfamethoxazole; Vancomycin | 2008 |
Common antibiotics for the treatment of urinary tract infections.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Costs; Humans; Nitrofurantoin; Nurse's Role; Ofloxacin; Patient Education as Topic; Patient Selection; Sulfamethoxazole; Urinary Tract Infections | 2008 |
pH induced polychromatic UV treatment for the removal of a mixture of SMX, OTC and CIP from water.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Hydrogen-Ion Concentration; Kinetics; Mass Spectrometry; Models, Chemical; Oxytetracycline; Photochemistry; Photolysis; Sulfamethoxazole; Ultraviolet Rays; Waste Disposal, Fluid; Water; Water Pollutants, Chemical; Water Purification | 2010 |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim | 2010 |
Removal of oseltamivir (Tamiflu) and other selected pharmaceuticals from wastewater using a granular bioplastic formulation entrapping propagules of Phanerochaete chrysosporium.
Topics: Anti-Infective Agents; Biodegradation, Environmental; Ciprofloxacin; Erythromycin; Oseltamivir; Phanerochaete; Polymers; Sulfamethoxazole; Waste Disposal, Fluid; Water Pollutants, Chemical; Xenobiotics | 2010 |
In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Doxycycline; Erythromycin; Fluorouracil; Fosfomycin; Leptospira; Microbial Sensitivity Tests; Neomycin; Philippines; Rats; Sulfamethoxazole; Trimethoprim; Vancomycin | 2010 |
Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro.
Topics: Anti-Bacterial Agents; Berberine; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Ellagic Acid; Flavonoids; Gallic Acid; Hydroxybenzoates; Microbial Sensitivity Tests; Piperacillin; Polymyxin B; Pseudomonas aeruginosa; Rutin; Sulfamethoxazole; Tetracycline; Trimethoprim | 2010 |
Sorption of antibiotics to biofilm.
Topics: 1-Octanol; Adsorption; Anti-Bacterial Agents; Biofilms; Bioreactors; Ciprofloxacin; Erythromycin; Hardness; Hydrogen-Ion Concentration; Organic Chemicals; Regression Analysis; Sulfamethoxazole; Waste Disposal, Fluid; Water | 2011 |
Toxic effects of erythromycin, ciprofloxacin and sulfamethoxazole on photosynthetic apparatus in Selenastrum capricornutum.
Topics: Anti-Bacterial Agents; Ca(2+) Mg(2+)-ATPase; Chlorophyll; Chlorophyta; Ciprofloxacin; Electron Transport; Erythromycin; Fluorescence; Photophosphorylation; Photosynthesis; Ribulose-Bisphosphate Carboxylase; Sulfamethoxazole; Water Pollutants, Chemical | 2011 |
Effects of pH and ionic strength on sulfamethoxazole and ciprofloxacin transport in saturated porous media.
Topics: Anti-Infective Agents; Ciprofloxacin; Groundwater; Hydrodynamics; Hydrogen-Ion Concentration; Models, Theoretical; Osmolar Concentration; Porosity; Silicon Dioxide; Soil Pollutants; Sulfamethoxazole; Water Pollutants, Chemical | 2011 |
Measurement of trace levels of antibiotics in river water using on-line enrichment and triple-quadrupole LC-MS/MS.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Erythromycin; Fluoroquinolones; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Oxolinic Acid; Reproducibility of Results; Rivers; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Tetracycline; Trimethoprim; Tylosin; Vancomycin; Water Pollutants, Chemical | 2011 |
Two fluoroalcohols as components of basic buffers for liquid chromatography electrospray ionization mass spectrometric determination of antibiotic residues.
Topics: Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Drug Residues; Lactuca; Mass Spectrometry; Norfloxacin; Ofloxacin; Propanols; Spectrometry, Mass, Electrospray Ionization; Sulfadimethoxine; Sulfamethoxazole | 2011 |
Effect of solar radiation on multidrug resistant E. coli strains and antibiotic mixture photodegradation in wastewater polluted stream.
Topics: Amoxicillin; Anti-Bacterial Agents; Chlorine; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Halogenation; Italy; Microbial Sensitivity Tests; Photolysis; Rivers; Sulfamethoxazole; Sunlight; Waste Disposal, Fluid; Water Pollutants, Chemical | 2012 |
An initial screening of antibiotic effects on microbial respiration in wetland soils.
Topics: Analysis of Variance; Anti-Bacterial Agents; Carbon Dioxide; Chromatography, Gas; Ciprofloxacin; Dose-Response Relationship, Drug; Environmental Pollutants; Louisiana; Methane; Nitrogen; Oxygen Consumption; Soil Microbiology; Sulfamethoxazole; Tetracycline; Wetlands | 2012 |
Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Typing Techniques; Bangladesh; Base Sequence; beta-Lactamases; Cholera; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Erythromycin; Furazolidone; Genetic Variation; Gentamicins; Humans; Microbial Sensitivity Tests; Sequence Alignment; Sequence Analysis, DNA; Sulfamethoxazole; Tetracycline; Trimethoprim; Vibrio cholerae O1 | 2012 |
Toxic effects of erythromycin, ciprofloxacin and sulfamethoxazole exposure to the antioxidant system in Pseudokirchneriella subcapitata.
Topics: Anti-Bacterial Agents; Catalase; Chlorophyta; Ciprofloxacin; Erythromycin; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Lipid Peroxidation; Sulfamethoxazole; Superoxide Dismutase; Water Pollutants, Chemical | 2013 |
Integrons, β-lactamase and qnr genes in multidrug resistant clinical isolates of Proteus mirabilis and P. vulgaris.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Proteus mirabilis; Proteus vulgaris; Sequence Analysis, DNA; Sulfamethoxazole; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey.
Topics: Animals; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Ciprofloxacin; DNA Primers; Gentamicins; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Rifampin; Sheep; Sheep Diseases; Streptomycin; Sulfamethoxazole; Tetracycline; Trimethoprim; Turkey | 2013 |
Advanced treatment of urban wastewater by UV radiation: Effect on antibiotics and antibiotic-resistant E. coli strains.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Disinfection; Drug Resistance, Microbial; Escherichia coli; Halogenation; Photolysis; Sulfamethoxazole; Ultraviolet Rays; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Water Purification | 2013 |
Occurrence and fate of PPCPs and correlations with water quality parameters in urban riverine waters of the Pearl River Delta, South China.
Topics: Acetaminophen; Caffeine; Carbamazepine; Carbon; China; Ciprofloxacin; DEET; Environmental Monitoring; Erythromycin; Nitrates; Nitrites; Nitrogen; Pharmaceutical Preparations; Quaternary Ammonium Compounds; Rivers; Sulfamethoxazole; Trimethoprim; Water Pollutants, Chemical; Water Quality | 2013 |
Degradation of ciprofloxacin and sulfamethoxazole by ferrous-activated persulfate: implications for remediation of groundwater contaminated by antibiotics.
Topics: Anti-Bacterial Agents; Chelating Agents; Ciprofloxacin; Citric Acid; Edetic Acid; Environmental Restoration and Remediation; Ferrous Compounds; Groundwater; Hydrogen-Ion Concentration; Sulfamethoxazole; Sulfates; Water Pollutants, Chemical | 2014 |
Removal of sulfamethoxazole and ciprofloxacin from aqueous solutions by graphene oxide.
Topics: Adsorption; Anti-Bacterial Agents; Ciprofloxacin; Graphite; Hydrogen-Ion Concentration; Osmolar Concentration; Oxides; Solutions; Sulfamethoxazole; Water Pollutants, Chemical; Water Purification | 2015 |
Toxicity of ciprofloxacin and sulfamethoxazole to marine periphytic algae and bacteria.
Topics: Anti-Bacterial Agents; Bacteria; Biofilms; Biomass; Chlorophyta; Ciprofloxacin; Sulfamethoxazole; Water Pollutants, Chemical | 2014 |
Assessing the concentrations and risks of toxicity from the antibiotics ciprofloxacin, sulfamethoxazole, trimethoprim and erythromycin in European rivers.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Environmental Monitoring; Erythromycin; Europe; Rivers; Sulfamethoxazole; Trimethoprim; Water Pollutants, Chemical; Water Pollution, Chemical | 2015 |
Parameters influencing ciprofloxacin, ofloxacin, amoxicillin and sulfamethoxazole retention by natural and converted calcium phosphates.
Topics: Adsorption; Amoxicillin; Anti-Bacterial Agents; Calcium Phosphates; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Residues; Durapatite; Hydrogen-Ion Concentration; Kinetics; Ofloxacin; Powders; Sulfamethoxazole | 2015 |
[Adsorption characteristics of typical PPCPs onto river sediments and its influencing factors].
Topics: Adsorption; Ciprofloxacin; Drug Residues; Geologic Sediments; Kinetics; Rivers; Sulfamethoxazole; Temperature; Tetracycline; Triclosan | 2015 |
Toxicological assessment of hospital wastewater in different treatment processes.
Topics: Animals; Anti-Bacterial Agents; Chlorella vulgaris; Ciprofloxacin; Cladocera; Fluoroquinolones; Halogenation; Hospitals; Scenedesmus; Sewage; Sulfamethoxazole; Thailand; Wastewater; Water Pollutants, Chemical | 2018 |
Sulfamethoxazole and ciprofloxacin removal using a horizontal-flow anaerobic immobilized biomass reactor.
Topics: Anaerobiosis; Biological Oxygen Demand Analysis; Biomass; Bioreactors; Chromatography, Liquid; Ciprofloxacin; Sulfamethoxazole; Tandem Mass Spectrometry; Water Pollutants, Chemical; Water Purification | 2016 |
Characteristics of bacterial acute diarrhea among women.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Brazil; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; Diarrhea; Dysentery, Bacillary; Female; Humans; Microbial Sensitivity Tests; Pregnancy; Retrospective Studies; Salmonella; Salmonella Infections; Shigella; Sulfamethoxazole; Trimethoprim; Young Adult | 2016 |
Growth Behavior of E. coli, Enterococcus and Staphylococcus Species in the Presence and Absence of Sub-inhibitory Antibiotic Concentrations: Consequences for Interpretation of Culture-Based Data.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drinking Water; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Escherichia coli; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Sewage; Sulfamethoxazole; Trimethoprim; Vancomycin-Resistant Enterococci; Water Microbiology | 2016 |
Bisphenol-A removal by the halophyte Juncus acutus in a phytoremediation pilot: Characterization and potential role of the endophytic community.
Topics: Anti-Bacterial Agents; Bacteria; Benzhydryl Compounds; Ciprofloxacin; Drug Residues; Endophytes; Environmental Pollutants; Environmental Restoration and Remediation; Genotype; Metals; Phenols; Pilot Projects; Plant Roots; Salt-Tolerant Plants; Sulfamethoxazole; Wetlands | 2017 |
Stimulation effects of ciprofloxacin and sulphamethoxazole in Microcystis aeruginosa and isobaric tag for relative and absolute quantitation-based screening of antibiotic targets.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Energy Metabolism; Microcystis; Photosynthesis; Proteomics; Sulfamethoxazole; Water Pollutants, Chemical | 2017 |
Nocardia Bacteremia and Endocarditis in a Patient With a Sulfa Allergy.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Drug Hypersensitivity; Dyspnea; Endocarditis, Bacterial; Female; Humans; Middle Aged; Mitral Valve; Nocardia; Nocardia Infections; Sulfamethoxazole; Trimethoprim | 2016 |
Algae-mediated removal of selected pharmaceutical and personal care products (PPCPs) from Lake Mead water.
Topics: Chlorophyta; Ciprofloxacin; Cosmetics; Lakes; Pharmaceutical Preparations; Sulfamethoxazole; Triclosan; Water Pollutants, Chemical | 2017 |
Antimicrobial-resistant Escherichia coli and Enterococcus spp. isolated from Miranda donkey (Equus asinus): an old problem from a new source with a different approach.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus; Equidae; Escherichia coli; Kanamycin Kinase; Methyltransferases; Microbial Sensitivity Tests; Portugal; Sulfamethoxazole; Tetracycline; Trimethoprim; Virginiamycin | 2017 |
Pleural Nocardiosis in Immunocompetent Patient.
Topics: Administration, Intravenous; Adult; Anti-Bacterial Agents; Ciprofloxacin; Humans; Immunocompetence; Male; Nocardia; Nocardia Infections; Pleural Effusion; Sulfamethoxazole; Treatment Outcome | 2017 |
Fate of sulfamethoxazole, its main metabolite N-ac-sulfamethoxazole and ciprofloxacin in agricultural soils amended or not by organic waste products.
Topics: Adsorption; Agriculture; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Humans; Manure; Sewage; Soil; Sulfamethoxazole; Waste Products | 2018 |
Simultaneous removal of ciprofloxacin, norfloxacin, sulfamethoxazole by co-producing oxidative enzymes system of Phanerochaete chrysosporium and Pycnoporus sanguineus.
Topics: Anti-Bacterial Agents; Biotransformation; Ciprofloxacin; Coculture Techniques; Norfloxacin; Oxidation-Reduction; Oxidative Stress; Phanerochaete; Pycnoporus; Sulfamethoxazole | 2018 |
Emerging contaminants and nutrients synergistically affect the spread of class 1 integron-integrase (intI1) and sul1 genes within stable streambed bacterial communities.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Ciprofloxacin; Diclofenac; Drug Resistance, Microbial; Erythromycin; Genes, Bacterial; Integrases; Parabens; Rivers; Sulfamethoxazole; Wastewater; Water Pollutants | 2018 |
Anaerobic biodegradation of pharmaceutical compounds: New insights into the pharmaceutical-degrading bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria, Anaerobic; Biodegradation, Environmental; Ciprofloxacin; Estradiol; Nitrates; Sulfamethoxazole; Sulfates; Water Pollutants, Chemical | 2018 |
Persistence of the antibiotic sulfamethoxazole in river water alone or in the co-presence of ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Humans; In Situ Hybridization, Fluorescence; Rivers; Sulfamethoxazole; Water Pollutants, Chemical | 2018 |
Oxidative stress responses and cellular energy allocation changes in microalgae following exposure to widely used human antibiotics.
Topics: Animals; Anti-Bacterial Agents; Catalase; Chlorophyta; Ciprofloxacin; Clarithromycin; Energy Metabolism; Environmental Exposure; Erythromycin; Humans; Lipid Peroxidation; Microalgae; Oxidative Stress; Sulfamethoxazole; Superoxide Dismutase; Water Pollutants, Chemical | 2018 |
The design of a sunlight-focusing and solar tracking system: A potential application for the degradation of pharmaceuticals in water.
Topics: Anti-Infective Agents; Ciprofloxacin; Oxidation-Reduction; Photolysis; Solar Energy; Sulfamethoxazole; Sunlight; Water Pollutants, Chemical; Water Purification | 2019 |
Feasibility of anaerobic packed and structured-bed reactors for sulfamethoxazole and ciprofloxacin removal from domestic sewage.
Topics: Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Bioreactors; Brazil; Ciprofloxacin; Sewage; Sulfamethoxazole; Waste Disposal, Fluid; Water Pollutants, Chemical | 2019 |
Benzalkonium chloride alters phenotypic and genotypic antibiotic resistance profiles in a source water used for drinking water treatment.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Benzalkonium Compounds; Ciprofloxacin; Drinking Water; Drug Resistance, Bacterial; Drug Resistance, Microbial; Environmental Monitoring; Genes, Bacterial; Sulfamethoxazole; Triclosan; Wastewater; Water Microbiology; Water Pollutants, Chemical; Water Purification | 2020 |
Environmental Risk and Risk of Resistance Selection Due to Antimicrobials' Occurrence in Two Polish Wastewater Treatment Plants and Receiving Surface Water.
Topics: Anti-Infective Agents; Azithromycin; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Sewage; Sulfamethoxazole; Tandem Mass Spectrometry; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2020 |
Comparing root concentration factors of antibiotics for lettuce (Lactuca sativa) measured in rhizosphere and bulk soils.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Lactuca; Plant Roots; Rhizosphere; Soil; Soil Pollutants; Sulfamethoxazole; Trimethoprim; Tylosin | 2021 |
Influence of organic loading rate on ciprofloxacin and sulfamethoxazole biodegradation in anaerobic fixed bed biofilm reactors.
Topics: Anaerobiosis; Bacteria, Anaerobic; Biodegradation, Environmental; Biofilms; Bioreactors; Ciprofloxacin; Sewage; Sulfamethoxazole; Waste Disposal, Fluid | 2020 |
Repurposing of escitalopram oxalate and clonazepam in combination with ciprofloxacin and sulfamethoxazole-trimethoprim for treatment of multidrug-resistant microorganisms and evaluation of the cleavage capacity of plasmid DNA.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Citalopram; Clonazepam; DNA; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Plasmids; Sulfamethoxazole; Trimethoprim | 2021 |
Cytochrome P450 Inhibition by Antimicrobials and Their Mixtures in Rainbow Trout Liver Microsomes In Vitro.
Topics: Animals; Ciprofloxacin; Clotrimazole; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Erythromycin; Ketoconazole; Liver; Microsomes, Liver; Oncorhynchus mykiss; Sulfamethoxazole | 2022 |
Transport of Carbamazepine, Ciprofloxacin and Sulfamethoxazole in Activated Carbon: Solubility and Relationships between Structure and Diffusional Parameters.
Topics: Adsorption; Carbamazepine; Charcoal; Ciprofloxacin; Diffusion; Porosity; Solubility; Sulfamethoxazole; Water Pollutants, Chemical; Water Purification | 2021 |
Interaction of Carboxyalkylated Cellulose Nanocrystals and Antibiotics.
Topics: Alkylation; Anti-Bacterial Agents; Biocompatible Materials; Cellulose; Ciprofloxacin; Doxycycline; Materials Testing; Nanoparticles; Particle Size; Sulfamethoxazole | 2021 |
The Bacteriology of Skin Lesions in Patients with Hidradenitis Suppurativa Is Associated with Previous Antibiotic Treatment in the Community Setting: A Referral Center Experience.
Topics: Adult; Anti-Bacterial Agents; Bacteriology; Ciprofloxacin; Clindamycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Hidradenitis Suppurativa; Humans; Referral and Consultation; Rifampin; Sulfamethoxazole; Trimethoprim | 2022 |
A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Humans; Laos; Ofloxacin; Prevalence; Sulfamethoxazole; Trimethoprim | 2022 |
A HPLC-MS/MS method for screening of selected antibiotic adulterants in herbal drugs.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Methanol; Metronidazole; Sulfamethoxazole; Tandem Mass Spectrometry; Trimethoprim; Water | 2022 |
In silico toxicity evaluation for transformation products of antimicrobials, from aqueous photolysis degradation.
Topics: Anti-Infective Agents; Ciprofloxacin; Mutagens; Norfloxacin; Photolysis; Sulfamethoxazole; Water; Water Pollutants, Chemical | 2022 |
Influence of the hydraulic retention time on the removal of emerging contaminants in an anoxic-aerobic algal-bacterial photobioreactor coupled with anaerobic digestion.
Topics: Acetaminophen; Anaerobiosis; Bacteria, Aerobic; Bioreactors; Ciprofloxacin; Dexamethasone; Enrofloxacin; Ibuprofen; Naproxen; Photobioreactors; Progesterone; Sewage; Sulfamethoxazole; Tetracyclines; Trimethoprim; Tylosin; Waste Disposal, Fluid | 2022 |
Monitoring antimicrobial resistance trends in Salmonella spp. from poultry in Eastern Spain.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chickens; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Nalidixic Acid; Poultry; Salmonella; Spain; Sulfamethoxazole; Tetracycline; Turkeys | 2022 |
In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Escherichia coli; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Nitroquinolines; Sulfamethoxazole; Trimethoprim; Urinary Tract; Urinary Tract Infections | 2022 |
Community-Acquired Uropathogenic
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Ciprofloxacin; Colistin; Cross-Sectional Studies; Cuba; Escherichia coli Proteins; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli | 2022 |
Drug repurposing strategy: An emerging approach to identify potential therapeutics for treatment of bovine mastitis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bilirubin; Cattle; Cefoxitin; Ciprofloxacin; Drug Repositioning; Female; Gentamicins; Ivermectin; Ketoprofen; Mastitis, Bovine; Meloxicam; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxytetracycline; Rabbits; Staphylococcal Infections; Sulfamethoxazole; Tylosin; Vancomycin | 2022 |
Analysis of virulence genes, drug resistance detection, and pathogenicity in Enterococcus from farm animals.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Cattle; Cefotaxime; Chickens; Ciprofloxacin; Dogs; Drug Resistance; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Levofloxacin; Mice; Microbial Sensitivity Tests; Sulfamethoxazole; Swine; Vancomycin; Virulence; Virulence Factors | 2022 |
Patterns of antimicrobial resistance in Salmonella isolates from fattening pigs in Spain.
Topics: Animals; Anti-Bacterial Agents; Bayes Theorem; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella; Spain; Sulfamethoxazole; Swine | 2022 |
Association between prenatal antibiotics exposure and measures of fetal growth: A repeated-measure study.
Topics: Anti-Bacterial Agents; Birth Weight; Ciprofloxacin; Female; Fetal Development; Humans; Infant, Newborn; Maternal Exposure; Norfloxacin; Pregnancy; Premature Birth; Sulfamethoxazole; Tandem Mass Spectrometry | 2022 |
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Amlodipine; Amphotericin B; Australia; Case-Control Studies; Ciprofloxacin; Diclofenac; Furosemide; Humans; Ibuprofen; Metformin; Naproxen; Omeprazole; Primary Health Care; Ramipril; Simvastatin; Spironolactone; Sulfamethoxazole; Telmisartan; Trimethoprim; Valacyclovir; Zoledronic Acid | 2022 |
Characterization of oxacillin-resistant Staphylococcus lugdunensis isolated from sterile body fluids in a medical center in Taiwan: A 12-year longitudinal epidemiological study.
Topics: Anti-Bacterial Agents; Body Fluids; Ciprofloxacin; Erythromycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus lugdunensis; Sulfamethoxazole; Taiwan; Teicoplanin; Trimethoprim; Vancomycin | 2023 |
Bioaccumulation of antibiotics and resistance genes in lettuce following cattle manure and digestate fertilization and their effects on soil and phyllosphere microbial communities.
Topics: Animals; Anti-Bacterial Agents; Bioaccumulation; Cattle; Ciprofloxacin; Enrofloxacin; Fertilization; Fluoroquinolones; Genes, Bacterial; Lactuca; Manure; Microbiota; Soil; Soil Microbiology; Sulfamethoxazole | 2022 |
Pharmaceuticals in multi-media environment from the Jin River to adjacent marine embayment in Southeast China.
Topics: Anti-Bacterial Agents; China; Ciprofloxacin; Enrofloxacin; Environmental Monitoring; Pharmaceutical Preparations; Risk Assessment; Rivers; Sulfamethoxazole; Water; Water Pollutants, Chemical | 2023 |
Influence of microplastics on the transport of antibiotics in sand filtration investigated by AFM force spectroscopy.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Microplastics; Plastics; Porosity; Quartz; Sand; Spectrum Analysis; Sulfamethoxazole | 2023 |
Uptake and depuration of three common antibiotics in benthic organisms: Sea cucumber (Holothuria tubulosa), snakelocks anemone (Anemonia sulcata) and beadlet anemone (Actinia equina).
Topics: Anemone; Animals; Anti-Bacterial Agents; Ciprofloxacin; Holothuria; Humans; Sea Anemones; Sea Cucumbers; Sulfamethoxazole | 2023 |
Integrated adsorption and photocatalytic degradation based removal of ciprofloxacin and sulfamethoxazole antibiotics using Fc@rGO-ZnO nanocomposite in aqueous systems.
Topics: Adsorption; Anti-Bacterial Agents; Chlorella; Ciprofloxacin; Sulfamethoxazole; Water; Zinc Oxide | 2023 |
Health risk assessment for uptake and accumulation of pharmaceuticals in jute mallow (Corchorus olitorius) irrigated with treated hospital wastewater.
Topics: Acetaminophen; Agricultural Irrigation; Anti-Bacterial Agents; Ciprofloxacin; Corchorus; Diclofenac; Environmental Monitoring; Humans; Ibuprofen; Pharmaceutical Preparations; Risk Assessment; Soil; Soil Pollutants; Sulfamethoxazole; Tetracyclines; Wastewater; Water | 2023 |
Adsorptive removal of ciprofloxacin and sulfamethoxazole from aqueous matrices using sawdust and plastic waste-derived biochar: A sustainable fight against antibiotic resistance.
Topics: Adsorption; Charcoal; Ciprofloxacin; Drug Resistance, Microbial; Kinetics; Plastics; Sulfamethoxazole; Water Pollutants, Chemical | 2023 |
Translation of Machine Learning-Based Prediction Algorithms to Personalised Empiric Antibiotic Selection: A Population-Based Cohort Study.
Topics: Aged; Algorithms; Ampicillin; Anti-Bacterial Agents; Cefepime; Ciprofloxacin; Cohort Studies; Female; Gentamicins; Humans; Imipenem; Machine Learning; Male; Middle Aged; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 2023 |